Background: In acute myeloid leukemia (AML), the MDS1 and EVI1 complex locus - MECOM, also known as the ecotropic virus integration site 1 - EVI1, located in band 3q26, can be rearranged with a variety of partner chromosomes and partner genes. Here we report on a 57-year-old female with AML who presented with the rare translocation t(3;10)(q26;q21) involving the MECOM gene. Our aim was to identify the fusion partner on chromosome 10q21 and to characterize the precise nucleotide sequence of the chromosomal breakpoint. Methods. Cytogenetic and molecular-cytogenetic techniques, chromosome microdissection, next generation sequencing, long-range PCR and direct Sanger sequencing were used to map the chromosomal translocation. Results: Using a combination of cytogenetic and molecular approaches, we mapped the t(3;10)(q26;q21) to the single nucleotide level, revealing a fusion of the MECOM gene (3q26.2) and C10orf107 (10q21.2). Conclusions: The approach described here opens up new possibilities in characterizing acquired as well as congenital chromosomal aberrations. In addition, DNA sequences of chromosomal breakpoints may be a useful tool for unique molecular minimal residual disease target identification in acute leukemia patients. © 2014 Jancuskova et al.; licensee BioMed Central Ltd.
CITATION STYLE
Jancuskova, T., Plachy, R., Zemankova, L., Hardekopf, D. W., Stika, J., Zejskova, L., … Pekova, S. (2014). Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient. Molecular Cytogenetics, 7(1). https://doi.org/10.1186/1755-8166-7-47
Mendeley helps you to discover research relevant for your work.